Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 5
2012 3
2013 6
2014 18
2015 16
2016 17
2017 11
2018 16
2019 16
2020 10
2021 15
2022 14
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 34216310

120 results

Results by year

Filters applied: . Clear all
Page 1
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features.
Natsumeda M, Chang M, Gabdulkhaev R, Takahashi H, Tsukamoto Y, Kanemaru Y, Okada M, Oishi M, Okamoto K, Rodriguez FJ, Kakita A, Fujii Y, Schreck KC. Natsumeda M, et al. Brain Tumor Pathol. 2021 Jul;38(3):228-233. doi: 10.1007/s10014-021-00407-0. Epub 2021 Jul 3. Brain Tumor Pathol. 2021. PMID: 34216310
Epithelioid GBMs show a high percentage of BRAF V600E mutation.
Kleinschmidt-DeMasters BK, Aisner DL, Birks DK, Foreman NK. Kleinschmidt-DeMasters BK, et al. Am J Surg Pathol. 2013 May;37(5):685-98. doi: 10.1097/PAS.0b013e31827f9c5e. Am J Surg Pathol. 2013. PMID: 23552385 Free PMC article.
Adult classical glioblastoma with a BRAF V600E mutation.
Takahashi Y, Akahane T, Sawada T, Ikeda H, Tempaku A, Yamauchi S, Nishihara H, Tanaka S, Nitta K, Ide W, Hashimoto I, Kamada H. Takahashi Y, et al. World J Surg Oncol. 2015 Mar 11;13:100. doi: 10.1186/s12957-015-0521-x. World J Surg Oncol. 2015. PMID: 25885250 Free PMC article.
BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity.
Nakajima N, Nobusawa S, Nakata S, Nakada M, Yamazaki T, Matsumura N, Harada K, Matsuda H, Funata N, Nagai S, Nakamura H, Sasaki A, Akimoto J, Hirato J, Yokoo H. Nakajima N, et al. Brain Pathol. 2018 Sep;28(5):663-673. doi: 10.1111/bpa.12572. Epub 2017 Dec 5. Brain Pathol. 2018. PMID: 29105198 Free PMC article.
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Kanemaru Y, Natsumeda M, Okada M, Saito R, Kobayashi D, Eda T, Watanabe J, Saito S, Tsukamoto Y, Oishi M, Saito H, Nagahashi M, Sasaki T, Hashizume R, Aoyama H, Wakai T, Kakita A, Fujii Y. Kanemaru Y, et al. Acta Neuropathol Commun. 2019 Jul 25;7(1):119. doi: 10.1186/s40478-019-0774-7. Acta Neuropathol Commun. 2019. PMID: 31345255 Free PMC article.
120 results